ERBB2 and central nervous system cancer: Some suitable glioma-specific cell surface antigens have been identified, such as the EGF receptor (EGFR) and its variant EGFRvIII, HER2/neu, IL-13 receptor alpha chain 2 [6], and the EPH receptor A2 (EphA2) [7].